Trugraf

DIAGNOSTIC_TEST2 trials

Sponsors

Massachusetts General Hospital, Transplant Genomics, Inc.

Conditions

ImmunosuppressionKidney Transplant Rejection

Phase 4

Immune Monitoring to Facilitate Belatacept Monotherapy

CompletedNCT04177095

Massachusetts General HospitalImmunosuppression, Kidney Transplant Rejection

Start: 2020-02-11End: 2023-06-01Updated: 2023-12-04

Unknown Phase

Immunosuppression Management in Renal Transplant Recipients With Transplant Excellence Based on TruGraf Test

Transplant Genomics, Inc.Immunosuppression, Kidney Transplant Rejection

Start: 2021-06-03End: 2023-09-30Target: 75Updated: 2021-08-27